The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.
News from Cancer Discovery
- Ovarian Cancer Screening Falls Short
Massive 19-year trial finds that tests do not reduce mortality. - TKI–BiTE Combo Produces CMRs in Most with ALL
Ponatinib plus blinatumomab effective in newly diagnosed and relapsed or refractory disease. - Zenocutuzumab Shines in PDAC
Bispecific antibody well tolerated; good responses seen in different NRG1 fusion–positive cancers. - Preliminary Activity Seen with RAD51 Inhibitor
CYT-0851 elicits responses in hematologic and solid cancers.
Advertisement
Trending - Altmetric
- Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcomaLast mentioned on Thu Jun 03 2021
- Discovery of candidate DNA methylation cancer driver genesLast mentioned on Wed May 26 2021
- Medium-chain acyl CoA dehydrogenase protects mitochondria from lipid peroxidation in glioblastomaLast mentioned on Fri Jun 11 2021
- Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencingLast mentioned on Mon May 17 2021
- Cancer cells retrace a stepwise differentiation program during malignant progressionLast mentioned on Thu May 20 2021
- See more
